	Exploring the Impact of the Multimodal CAPABLE eHealth Intervention on Health-Related Quality of Life in Patients With Melanoma Undergoing Immune-Checkpoint Inhibition: Prospective Pilot Study. JMIR Cancer Fraterman I, Sacchi L, Mallo H, Tibollo V, Glaser SLC, Medlock S, Cornet R, Gabetta M, Hisko V, Khadakou V, Barkan E, Del Campo L, Glasspool D, Kogan A, Lanzola G, Leizer R, Ottaviano M, Peleg M, , Lisowska A, Wilk S, Parimbelli E, Quaglini S, Rizzo M, Locati LD, Boekhout A, van de Poll-Franse LV, Wilgenhof S. PMID: 39883020 [PubMed - indexed for MEDLINE]
	Enhancing immunotherapy efficacy with synergistic low-dose radiation in metastatic melanoma: current insights and prospects. J Exp Clin Cancer Res Rafiq Z, Kang M, Barsoumian HB, Manzar GS, Hu Y, Leuschner C, Huang A, Masrorpour F, Lu W, Puebla-Osorio N, Welsh JW. PMID: 39881333 [PubMed - indexed for MEDLINE]
	Challenges and perspectives in the management of BRAF-mutated metastatic melanoma: Systemic treatment sequencing and brain metastases. Cancer Treat Rev Martin-Liberal J, Márquez-Rodas I, Cerezuela-Fuentes P, Soria A, Garicano F, Medina J, García Galindo R, Oramas J, Luis Manzano J, Delgado M, Valdivia J, Sanchez P. PMID: 39879863 [PubMed - as supplied by publisher]
	MELANOMAS, SARCOMAS, AND RENAL METASTASES IN THE LIVER: HOW TO TREAT? Arq Bras Cir Dig Lucchese AM, Kalil AN, Diniz AL, Oldhafer KJ, Pawlik TM, Adam R, Soubrane O, Braghiroli MI, Cotta-Pereira RL, International Hepato-Pancreato-Biliary Association. PMID: 39879511 [PubMed - indexed for MEDLINE]
	Individualized Neoantigen-Directed Melanoma Therapy. Am J Clin Dermatol Khaddour K, Buchbinder EI. PMID: 39875711 [PubMed - as supplied by publisher]
	Risk of second primary malignancies among survivors of cutaneous melanoma: A nationwide population-based study in the Republic of Korea. Sci Rep Jung JM, Kim DH, Kim YJ, Moon IJ, Lee WJ, Chang SE, Lee MW, Won CH. PMID: 39875452 [PubMed - indexed for MEDLINE]
	Survival improvements in patients with melanoma brain metastases and leptomeningeal disease in the modern era: Insights from a nationwide study (2015-2022). Eur J Cancer Pedersen S, Johansen EL, Højholt KL, Pedersen MW, Mogensen AM, Petersen SK, Haslund CA, Donia M, Schmidt H, Bastholt L, Friis R, Svane IM, Ellebaek E. PMID: 39874911 [PubMed - as supplied by publisher]
	Temozolomide monotherapy versus combination therapies in melanoma: a meta-analysis of efficacy and safety. Melanoma Res Chen L, Cai B, Ni X, Lin Q, Ke R, Wan X, Huang T, Shan X, Wang B. PMID: 39874124 [PubMed - as supplied by publisher]
	Dual-energy CT iodine concentration as a biomarker for immunotherapy treatment response in metastatic melanoma and renal cell carcinoma patients. Eur Radiol Wiley N, Zecevic M, Ho V, Stolzberg MJ, Cox D, Soloff EV, Hall E, Wang CL. PMID: 39873753 [PubMed - as supplied by publisher]
	Early palliative care in metastatic uveal melanoma (early together): protocol of a prospective randomized Phase III trial. Melanoma Manag Piperno-Neumann S, Koning L, Marchal T, Gastaud L, Waechter L, Fogliarini A, Bouleuc C, Libert Y, Seban R, Thery L, Ducoulombier A, Rodrigues M, Bredart A, Savignoni A, Dolbeault S, Burnod A. PMID: 39869447 [PubMed]
	Immune checkpoint inhibitors in pediatric patients with melanoma: a systematic literature review. Melanoma Manag Vyas C, Moshyk A, Fusaro G, Zacharoulis S, Fazeli MS, Gaind N, Behyan S, Thakkar P. PMID: 39869446 [PubMed]
	Melanoma in a Colombian population: a survival study. Melanoma Manag Flórez MA, Moreno Gómez GA, Flórez MA, Bueno IL, Gómez JM, Gómez MM, Restrepo Gutiérrez JJ. PMID: 39869442 [PubMed]
	Is there still a place for lymph node dissection for stage III melanoma since the approval of adjuvant therapy. Curr Opin Oncol Mouna O, Hanssens C, Meyers M, Langouo M. PMID: 39869039 [PubMed - as supplied by publisher]
	Neoadjuvant immunotherapy in melanoma: pathological response as a surrogate endpoint? Curr Opin Oncol Meyers M, Mouna O, Langouo M. PMID: 39869008 [PubMed - as supplied by publisher]
	Melanoma-derived extracellular vesicles transfer proangiogenic factors. Oncol Res Wilczak M, Surman M, PRZYBY. PMID: 39866233 [PubMed - indexed for MEDLINE]
	Nivolumab and hypofractionated radiotherapy in patients with advanced melanoma: A phase 2 trial. Eur J Cancer Doyen J, Dompmartin A, Cruzel C, Stefan D, Arnault JP, Coutte A, Picard-Gauci A, Mansard S, Gleyzolle B, Fontas E, Long-Mira E, Mirabel X, Mortier L, Montaudié H. PMID: 39864364 [PubMed - as supplied by publisher]
	Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study. Sci Rep Majidova N, Arak H, Ozalp FR, Bas O, Koker GO, Ozmarasal, Karateke YS, Sakalar T, Yaslikaya S, Onur ID, Akdag G, Ogul A, Guliyev M, Sahin E, Delipoyraz EE, Alkan A, Ayd, Ilhan N, Alan O, Akbas S, Ca, Guren AK, Sever N, Ellez HI, Selcukbiricik F, Muhammed Atc, Bilici A, Demirci NS, Basoglu T, Karacin C, Kara IO, Y, Evrensel T, Karaca M, Dizdar O, Atag E, Ozgun A, Kostek O. PMID: 39863702 [PubMed - indexed for MEDLINE]
	Case report: Study of a bulky melanoma mimicking sarcoma. Int J Surg Case Rep Quack E, Fatouaki H, Afri E, Mastronicola R, Dolivet G. PMID: 39862670 [PubMed - as supplied by publisher]
	Detection of Circulating Tumor DNA in Liquid Biopsy: Current Techniques and Potential Applications in Melanoma. Int J Mol Sci Martínez-Vila C, Teixido C, Aya F, Martín R, González-Navarro EA, Alos L, Castrejon N, Arance A. PMID: 39859576 [PubMed - indexed for MEDLINE]
	Adjuvant Systemic Immunotherapies for Resected Stage III Melanoma: A Single-Centre Retrospective Clinical Practice Review. Int J Mol Sci Lefas AY, Cinar C, Sreekumar S, Pakzad F, Koliou P. PMID: 39859464 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 42173

Page 1 of 2109



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy